Skip to content

Observational study on clinical course and prognostic factors of amyotrophic lateral sclerosis (ALS)

Observational study on clinical course and prognostic factors of amyotrophic lateral sclerosis (ALS) - Observational study for amyotrophic lateral sclerosis (ALS)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000041729
Enrollment
600
Registered
2020-11-01
Start date
2020-10-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

amyotrophic lateral sclerosis

Interventions

None listed

Sponsors

Department of Neurology, Tohoku University Hospital
Lead Sponsor
Department of Neurology, Minami Tohoku Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who were diagnosed as "possible ALS", "probable ALs laboratory-supported", "probable ALS", or "definite ALS" in the El Escorial diagnostic criteria revised. Otherwise, patients who were diagnosed as "possible ALS", "probable ALs laboratory-supported", "probable ALS", or "definite ALS" in the updated Awaji criteria. Both sporadic and familial ALS patients will be assigned.

Exclusion criteria

Exclusion criteria: 1. Patients who have participated in a clinical trial for ALS and have been administered the investigational drug 2. Patients who have other serious complications and are considered unsuitable for the natural history survey by the investigator

Design outcomes

Primary

MeasureTime frame
1. ALSFRS-R change rate 2. Period from onset to death or tracheostomy/invasive positive pressure ventilation 3. Period from onset to full-day non-invasive positive pressure ventilation (>22 hours/day)

Countries

Japan

Contacts

Public ContactTomomi Shijo

Tohoku University Hospital Department of Neurology

shijo-t@med.tohoku.ac.jp022-717-7189

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026